Psychosocial Treatment

Drug addiction exacts a tremendous toll on individuals and society. Our scientists are engaged in the development and evaluation of approaches to increase entry and engagement in addiction treatment and to improve outcomes for patients enrolled in such treatment. Typically, the effectiveness of different psychosocial strategies is determined through the use of randomized clinical trials. Additionally, our scientists conduct longitudinal outcome studies using both quantitative and ethnographic approaches in order to discover ways of improving existing treatments. These two methods provide insight into what works and why it works and enable treatment providers and policymakers to improve treatment systems and to reduce the harmful impact addiction has on individuals, families and society.

FRI scientists currently working within this field include the following:

Lead Scientists Elizabeth E. Katz, Ph.D
Collaborating Scientist Thomas E. Hanlon, Ph.D.
Jerome H. Jaffe, M.D.
Sharon M. Kelly, Ph.D.
Timothy W. Kinlock, Ph.D.
Shannon Gwin Mitchell, Ph.D.
Robert P. Schwartz, M.D.
Monique E. Wilson, Dr.P.H.